Head Injury on Anticoagulation — MRCEM SBA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Continue apixaban as usual
This is a minor head injury in a patient taking a DOAC, with GCS 15, normal neurological examination and no intracranial haemorrhage on CT. In this setting, apixaban should be continued as usual. There is no indication to reverse anticoagulation or switch to warfarin, and routinely withholding apixaban after a normal CT exposes an older patient with atrial fibrillation to avoidable thromboembolic stroke risk. Appropriate management is discharge with standard head-injury safety-net advice, including return if headache, vomiting, confusion, drowsiness, seizure, weakness or other neurological symptoms develop.
Reference: BMJ Practice Pointer: Head injury in older people taking anticoagulants, 2025. https://www.bmj.com/content/389/bmj-2024-080736